Table 2.
Evidence profile with GRADE pro for the three meta-analyses.
| Certainty assessment | No. of subjects | Size of the effect | Quality of evidence | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N of studies | Study design | Risk of bias | Inconsistency | Indirect evidence | Imprecision | Other considerations | MetS+ | MetS− | Difference of averages (95% CI) | |
| Meta-analysis 1 | ||||||||||
| n = 56 | Observational studies | Very serious | It is not serious | It is not serious | Dose–response gradient | 91,845 | 259,931 | 0,57 (0.54–0.61) |
⨁◯◯◯ Very low |
|
| Meta-analysis 2 | ||||||||||
| n = 17 | Observational studies | Very serious | It is not serious | It is not serious | Dose–response gradient | 19,165 | 86,883 | 0.53 (0.45–0.62) |
⨁◯◯◯ Very low |
|
| Meta-analysis 3 | ||||||||||
| n = 15 | Observational studies | Very serious | It is not serious | It is not serious | Dose–response gradient | 14,823 | 43,471 | 0.57 (0.48–0.66) |
⨁◯◯◯ Very low |
|
MetS metabolic syndrome, CI confidence interval.